Prescient Therapeutics

About:

Prescient Therapeutics is a biopharmaceutical company, discovers and develops novel immunotherapeutic products for the treatment of chronic.

Website: https://ptxtherapeutics.com/

Twitter/X: ptx_aus

Description:

Prescient Therapeutics (PTX) is a clinical stage oncology company developing novel compounds that show great promise as potential new therapies to treat a range of solid and hematological cancers.

Total Funding Amount:

$3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

South Melbourne, Victoria, Australia

Founded Date:

1999-01-01

Contact Email:

justin(AT)ptxtherapeutics.com

Founders:

Said Sebti

Number of Employees:

1-10

Last Funding Date:

2014-03-24

IPO Status:

Public

Industries:

© 2025 bioDAO.ai